Cancer cells have many “plan Bs” and “plan Cs”!
A staggering figure of 2.8 million is the annual score (in the US alone) for antibiotic-resistant infections, according to the US CDC. Sadly, by far the worst infection ever is now the ruthless, very fast-spreading COVID-19 variants that may even elude immune responses derived from vaccinations. On the other hand, in the mid-2010s, with the […]
Although high dose intravenous vitamin C is highly pleiotropic and has a good potential to be an excellent adjunctive oncology agent, many details have to be worked out. At present, it is inappropriate to hail it as a panacea of cancer therapy nor is it a well-recognized alternative to orthodox modalities of cancer treatments.